Search filters

List of works by Douglas B. Johnson

A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis

scientific article published on 22 July 2019

A phase II trial of erlotinib and bevacizumab for patients with metastatic melanoma

scientific article

BRAF internal deletions and resistance to BRAF/MEK inhibitor therapy.

scientific article published on 24 November 2017

Breakthrough concepts in immune-oncology: Cancer vaccines at the bedside

scientific article published on 18 June 2020

Health care utilization and steroid-refractory toxicities from immune checkpoint inhibitors

scientific article published on 03 October 2019

Immune Checkpoint Inhibitors Associated Primary Adrenal Insufficiency: WHO VigiBase Report Analysis

scientific article published on 10 May 2020

Immune checkpoint inhibitors in challenging populations

scientific article

Incidence, features and management of radionecrosis in melanoma patients treated with cerebral radiotherapy and anti-PD-1 antibodies

scientific article published on 03 March 2019

Melanoma: What do all the mutations mean?

scientific article published on 17 April 2018

Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study

article

Outcomes after progression of disease with anti-PD-1/PD-L1 therapy for patients with advanced melanoma

scientific article published on 28 May 2020

Tolerance and efficacy of BRAF plus MEK inhibition in patients with melanoma who previously have received programmed cell death protein 1-based therapy

scientific article published on 06 December 2018

Toxicities and outcomes: Do steroids matter?

scientific article published on 05 July 2018

Paulina is supported by:

About Paulina

Help